Vontier Earns Top Accolade at International Sustainability Awards
Scripps Cancer Center Leader Receives National Accolade
Defining Wellness Centers Names Bill Morrison Chief Financial Officer
CoinEx Wins Top Accolade for Cryptocurrency Exchange at International Business Magazine Awards 2025
TalkingParents Takes Home 11th Accolade For Support Network Initiative
The One Show Announces Historic Win: Klick Health Becomes First Health Agency to Ever Receive An Agency of the Year Accolade
Wellspring Launches Next-Gen Innovation Platform, Accolade Core
Pernod completes sale of wine portfolio to Accolade Wines owner
Digital health startup Transcarent takes Accolade private in $621 million deal
Transcarent Completes Merger With Accolade
Accolade Stockholders Approve Merger Between Accolade and Transcarent
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade
Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
Why Is Accolade Stock Trading Over 100% On Tuesday?
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Transcarent To Acquire Accolade
Transcarent To Acquire Accolade
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
Accolade: A GARP Stock Trading Well Under 1X Revenues
Accolade (ACCD) Upgraded to Buy: Here's Why
Accolade To Present at Upcoming Investor Conferences
Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Accolade Welcomes Renalogic to Trusted Partner Ecosystem
Accolade (ACCD) Upgraded to Buy: Here's What You Should Know
Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30
Accolade Announces Results for Fiscal Second Quarter 2025
Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
Accolade to Announce Fiscal Second Quarter 2025 Financial Results
Tri Pointe Homes Receives 2024 People Companies That Care® Accolade and 2024 Fortune Best Workplaces in Construction™ Distinction
All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD)
Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Accolade, Inc. (ACCD) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Accolade, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ACCD
Accolade, Inc. (ACCD) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
Accolade Being Investigated on Behalf of Accolade, Inc. Investors. Contact Levi & Korsinsky For Details.
First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies
Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations
Lost Money on Accolade, Inc.(ACCD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Did Accolade, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ACCD